DR
Drew Ranieri Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Globus Medical
GMED
$7.89B
| $58.44 | $68 |
16%
upside
| Overweight |
15 Jul ‘25
1 month ago |
|
2
Organogenesis Holdings
ORGO
$617M
| $4.86 | $6 |
23%
upside
| Equal-Weight |
5 Mar ‘25
6 months ago |
|
3
Alphatec Holdings
ATEC
$2.27B
| $15.35 | $10 |
35%
downside
| Equal-Weight |
2 Dec ‘24
9 months ago |
|
4
Stryker
SYK
$146B
| $382.97 | $445 |
16%
upside
| Overweight |
2 Dec ‘24
9 months ago |
|
5
SI-BONE Inc
SIBN
$676M
| $15.66 | $19 |
21%
upside
| Overweight |
6 Aug ‘24
1 year ago |
|
6
Integra LifeSciences
IART
$1.2B
| $15.39 | $27 |
75%
upside
| Underweight |
15 Jul ‘24
1 year ago |
|
7
Treace Medical Concepts
TMCI
$442M
| $7 | $8 |
14%
upside
| Equal-Weight |
15 Jul ‘24
1 year ago |
|
8
Stevanato
STVN
$7.05B
| $25.84 | $22 |
15%
downside
| Equal-Weight |
15 Jul ‘24
1 year ago |
|
9
Neuropace
NPCE
$320M
| $9.67 | $8 |
17%
downside
| Equal-Weight |
15 Jul ‘24
1 year ago |
|
10
Outset Medical
OM
$241M
| $13.54 | $82.50 |
509%
upside
| Equal-Weight |
4 Dec ‘23
1 year ago |
|
11
Envista
NVST
$3.45B
| $20.77 | $38 |
83%
upside
| Overweight |
2 Nov ‘23
1 year ago |
|
12
Haemonetics
HAE
$2.59B
| $53.67 | $96 |
79%
upside
| Equal-Weight |
12 May ‘23
2 years ago |
|
13
Avanos Medical
AVNS
$558M
| $12.02 | $26 |
116%
upside
| Underweight |
4 May ‘23
2 years ago |
|
14
Becton Dickinson
BDX
$54B
| $188.43 | $295 |
57%
upside
| Overweight |
3 Feb ‘23
2 years ago |
|
15
Teleflex
TFX
$5.76B
| $130.29 | $280 |
115%
upside
| Equal-Weight |
6 Jan ‘23
2 years ago |
|
16
Bioventus
BVS
$468M
| $7 | $5 |
29%
downside
| Overweight |
10 Nov ‘22
2 years ago |
|
17
Baxter International
BAX
$12.3B
| $23.98 | $70 |
192%
upside
| Overweight |
11 Oct ‘22
2 years ago |
|
18
Intuitive Surgical
ISRG
$161B
| $449.98 | $300 |
33%
downside
| Equal-Weight |
25 Apr ‘22
3 years ago |
|